Thank you for your interest in viewing the ALS Unfiltered 2018 Webinar: Important & Currently Enrolling ALS Clinical Trials webinar!
September 25, 2018
The goal of our webinars is to provide direct answers to people with ALS, their families and others involved or interested in research leading to the development of effective treatments and cures for ALS.
This session will review the three Phase 3 trials enrolling people with ALS in the US/EU right now: NurOwn, levosimendan, and arimoclomol as well as major Phase 2 trials, such as reldesemtiv.
Please provide the following information so we can continue to make our Webinars relevant for the entire ALS community
* = Required Fields
Register now for our upcoming webinar on May 10th at 6pm: FDA approves Radicava - What do we need to know?
#WHATWOULDYOUGIVE to #ENDALS?
For ALS Awareness Month, join our #InThreeWords campaign on social media.
You can be a hero and give to ALS TDI to help us get more promising treatments out of our lab and into people living with ALS.
November 27 is
You've taken the challenge, now help
move promising treatments out of our
lab and into people living with ALS.
The 2018 Combined Federal Campaign has officially launched!
Help us continue to move more potential treatments into the clinic!
Stay up to date with ALS TDI by subscribing to our newsletter today!
Join the Ride to #EndALS